NOVOS
Founded 2018 · 34 employees on LinkedIn · 8 known investors
Find your way into NOVOS
136 people in our graph share verified history with the NOVOS team — schools, employers, funds. One of them is your warm intro.
Steve Murrayunlockedknows Chris Mirabile · together at Convene (overlapped)
×10knows the team · via NYU Stern School of Business
knows the team · via NOVOS
NOVOS is a longevity biotechnology company that develops science-validated supplement formulations and aging assessment tools designed to target the biological mechanisms of aging rather than disease symptoms. The company serves consumers seeking to extend healthspan through evidence-based products backed by clinical trials and mechanistic research.
Founders & leadership
NOVOS was founded in 2018 by Chris Mirabile.
CM
Chris MirabileinFounder & CEOChris Mirabile is founder and CEO of NOVOS, a longevity biotechnology company developing supplement formulations and aging assessment tools. He leads a team that includes advisors and researchers from institutions including Harvard and MIT.
Investors · 8
Cornucopian Capital ManagementMontclair
Fab Co-Creation Studio VenturesSan Francisco · $250K – $1Mvia Odile Roujol · inferred
Resolute VenturesSan Francisco · $1M
Kaedan CapitalreportedTel Aviv
.png)
MizMaa VenturesreportedTel Aviv · $1M – $6M
Remagine Venturesreported · 2 sourcesTel Aviv
UNCOMMON DENOMINATORreportedNew York
Also in the syndicate · 1
Gal Ventures
Funding
SEC filings, press & company announcements- Undisclosed amountSeed roundApr 2022
MizMaa Ventures (lead), Gal Ventures, Kaedan Capital, Remagine ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does NOVOS do?
- NOVOS is a longevity biotechnology company that develops science-validated supplement formulations and aging assessment tools designed to target the biological mechanisms of aging rather than disease symptoms. The company serves consumers seeking to extend healthspan through evidence-based products backed by clinical trials and mechanistic research.
- Who founded NOVOS?
- NOVOS was founded by Chris Mirabile in 2018.
- Who are NOVOS's investors?
- NOVOS's investors include Cornucopian Capital Management, Fab Co-Creation Studio Ventures, Resolute Ventures, Kaedan Capital, MizMaa Ventures, Remagine Ventures, UNCOMMON DENOMINATOR.